Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
1(11%)
Results Posted
83%(5 trials)

Phase Distribution

Ph phase_2
4
44%
Ph phase_3
3
33%
Ph not_applicable
1
11%
Ph phase_1
1
11%

Phase Distribution

1

Early Stage

4

Mid Stage

3

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
1(11.1%)
Phase 2Efficacy & side effects
4(44.4%)
Phase 3Large-scale testing
3(33.3%)
N/ANon-phased studies
1(11.1%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

9

all time

Status Distribution
Active(2)
Completed(6)
Other(1)

Detailed Status

Completed6
unknown1
Recruiting1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (11.1%)
Phase 24 (44.4%)
Phase 33 (33.3%)
N/A1 (11.1%)

Trials by Status

completed667%
unknown111%
recruiting111%
not_yet_recruiting111%

Recent Activity

1 active trials
Showing 5 of 9
recruitingphase_2

Co-infusion of Treg-enriched Donor Lymphocytes With CD3-depleted Hematopoietic Stem Cell Graft to Prevent Graft-versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation Among Children With Hematologic Malignancies

NCT07366801
not_yet_recruitingphase_3

A Study of Romiplostim N01 Plus IST vs. Placebo Plus IST for Treatment-Naive Severe Aplastic Anemia

NCT07345000
completedphase_2

Combination of Eltrombopag With Immunosuppressive Therapy in East-Asian Patients With Severe Aplastic Anemia

NCT04328727
completedphase_2

Safety and Efficacy of Pentostatin and Low Dose TBI With Allogenic Peripheral Blood Stem Cell Transplant

NCT00571662
completednot_applicable

Photophoresis Versus Ciclosporine in Severe Atopic Dermatitis

NCT02226068
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT07366801Phase 2

Co-infusion of Treg-enriched Donor Lymphocytes With CD3-depleted Hematopoietic Stem Cell Graft to Prevent Graft-versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation Among Children With Hematologic Malignancies

Recruiting
NCT07345000Phase 3

A Study of Romiplostim N01 Plus IST vs. Placebo Plus IST for Treatment-Naive Severe Aplastic Anemia

Not Yet Recruiting
NCT04328727Phase 2

Combination of Eltrombopag With Immunosuppressive Therapy in East-Asian Patients With Severe Aplastic Anemia

Completed
NCT00571662Phase 2

Safety and Efficacy of Pentostatin and Low Dose TBI With Allogenic Peripheral Blood Stem Cell Transplant

Completed
NCT02226068Not Applicable

Photophoresis Versus Ciclosporine in Severe Atopic Dermatitis

Completed
NCT02091414Phase 3

A Study of CellCept (Mycophenolate Mofetil) in Combination Therapy in Heart Transplant Patients.

Completed
NCT00741338Phase 1

Immune Tolerance Study With Aldurazyme® (Laronidase)

Completed
NCT00251004Phase 3

Efficacy and Safety Study of Everolimus Plus Reduced Cyclosporine Versus Mycophenolic Acid Plus Cyclosporine in Kidney Transplant Recipients

Completed
NCT01129739Phase 2

Safety and Efficacy Study of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to Treat Myelodysplastic Syndromes

Unknown

All 9 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
9